- $184.29m
- $322.20m
- $489.27m
- 37
- 71
- 88
- 71
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 490 | 428 | 478 | 499 | 489 |
Cost of Revenue | |||||
Gross Profit | 97 | 83.9 | 87.6 | 77.6 | 70.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 508 | 545 | 489 | 520 | 511 |
Operating Profit | -18.1 | -118 | -11.4 | -21.1 | -21.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -32.1 | -152 | -22.4 | -31.1 | -53.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -32.4 | -143 | -20.7 | -32.7 | -56 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -46.7 | -101 | -13.2 | -26.1 | -50.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -47.4 | -113 | -34.7 | -37 | -63.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.729 | -2.1 | -0.78 | -0.828 | -1.35 |
Dividends per Share |